149 related articles for article (PubMed ID: 27354694)
1. Evaluating the molecule-based prediction of clinical drug responses in cancer.
Ding Z; Zu S; Gu J
Bioinformatics; 2016 Oct; 32(19):2891-5. PubMed ID: 27354694
[TBL] [Abstract][Full Text] [Related]
2. Identifying cancer-related microRNAs based on gene expression data.
Zhao XM; Liu KQ; Zhu G; He F; Duval B; Richer JM; Huang DS; Jiang CJ; Hao JK; Chen L
Bioinformatics; 2015 Apr; 31(8):1226-34. PubMed ID: 25505085
[TBL] [Abstract][Full Text] [Related]
3. OncomiRDB: a database for the experimentally verified oncogenic and tumor-suppressive microRNAs.
Wang D; Gu J; Wang T; Ding Z
Bioinformatics; 2014 Aug; 30(15):2237-8. PubMed ID: 24651967
[TBL] [Abstract][Full Text] [Related]
4. Dissecting the biological relationship between TCGA miRNA and mRNA sequencing data using MMiRNA-Viewer.
Bai Y; Ding L; Baker S; Bai JM; Rath E; Jiang F; Wu J; Jiang H; Stuart G
BMC Bioinformatics; 2016 Oct; 17(Suppl 13):336. PubMed ID: 27766936
[TBL] [Abstract][Full Text] [Related]
5. IntegratedMRF: random forest-based framework for integrating prediction from different data types.
Rahman R; Otridge J; Pal R
Bioinformatics; 2017 May; 33(9):1407-1410. PubMed ID: 28334269
[TBL] [Abstract][Full Text] [Related]
6. Cancer driver gene discovery through an integrative genomics approach in a non-parametric Bayesian framework.
Yang H; Wei Q; Zhong X; Yang H; Li B
Bioinformatics; 2017 Feb; 33(4):483-490. PubMed ID: 27797769
[TBL] [Abstract][Full Text] [Related]
7. Modeling gene-wise dependencies improves the identification of drug response biomarkers in cancer studies.
Nikolova O; Moser R; Kemp C; Gönen M; Margolin AA
Bioinformatics; 2017 May; 33(9):1362-1369. PubMed ID: 28082455
[TBL] [Abstract][Full Text] [Related]
8. MIRAGAA--a methodology for finding coordinated effects of microRNA expression changes and genome aberrations in cancer.
Gaire RK; Bailey J; Bearfoot J; Campbell IG; Stuckey PJ; Haviv I
Bioinformatics; 2010 Jan; 26(2):161-7. PubMed ID: 19933823
[TBL] [Abstract][Full Text] [Related]
9. A co-module approach for elucidating drug-disease associations and revealing their molecular basis.
Zhao S; Li S
Bioinformatics; 2012 Apr; 28(7):955-61. PubMed ID: 22285830
[TBL] [Abstract][Full Text] [Related]
10. Drug response prediction by inferring pathway-response associations with kernelized Bayesian matrix factorization.
Ammad-Ud-Din M; Khan SA; Malani D; Murumägi A; Kallioniemi O; Aittokallio T; Kaski S
Bioinformatics; 2016 Sep; 32(17):i455-i463. PubMed ID: 27587662
[TBL] [Abstract][Full Text] [Related]
11. GDSCTools for mining pharmacogenomic interactions in cancer.
Cokelaer T; Chen E; Iorio F; Menden MP; Lightfoot H; Saez-Rodriguez J; Garnett MJ
Bioinformatics; 2018 Apr; 34(7):1226-1228. PubMed ID: 29186349
[TBL] [Abstract][Full Text] [Related]
12. Optimal drug prediction from personal genomics profiles.
Sheng J; Li F; Wong ST
IEEE J Biomed Health Inform; 2015 Jul; 19(4):1264-70. PubMed ID: 25781964
[TBL] [Abstract][Full Text] [Related]
13. Fast dimension reduction and integrative clustering of multi-omics data using low-rank approximation: application to cancer molecular classification.
Wu D; Wang D; Zhang MQ; Gu J
BMC Genomics; 2015 Dec; 16():1022. PubMed ID: 26626453
[TBL] [Abstract][Full Text] [Related]
14. Improved anticancer drug response prediction in cell lines using matrix factorization with similarity regularization.
Wang L; Li X; Zhang L; Gao Q
BMC Cancer; 2017 Aug; 17(1):513. PubMed ID: 28768489
[TBL] [Abstract][Full Text] [Related]
15. Alternative preprocessing of RNA-Sequencing data in The Cancer Genome Atlas leads to improved analysis results.
Rahman M; Jackson LK; Johnson WE; Li DY; Bild AH; Piccolo SR
Bioinformatics; 2015 Nov; 31(22):3666-72. PubMed ID: 26209429
[TBL] [Abstract][Full Text] [Related]
16. Reconstructing cancer drug response networks using multitask learning.
Ruffalo M; Stojanov P; Pillutla VK; Varma R; Bar-Joseph Z
BMC Syst Biol; 2017 Oct; 11(1):96. PubMed ID: 29017547
[TBL] [Abstract][Full Text] [Related]
17. Identifying novel associations between small molecules and miRNAs based on integrated molecular networks.
Lv Y; Wang S; Meng F; Yang L; Wang Z; Wang J; Chen X; Jiang W; Li Y; Li X
Bioinformatics; 2015 Nov; 31(22):3638-44. PubMed ID: 26198104
[TBL] [Abstract][Full Text] [Related]
18. The Cancer Genome Atlas Clinical Explorer: a web and mobile interface for identifying clinical-genomic driver associations.
Lee H; Palm J; Grimes SM; Ji HP
Genome Med; 2015 Oct; 7():112. PubMed ID: 26507825
[TBL] [Abstract][Full Text] [Related]
19. Integrated Cancer Subtyping using Heterogeneous Genome-Scale Molecular Datasets.
Arslanturk S; Draghici S; Nguyen T
Pac Symp Biocomput; 2020; 25():551-562. PubMed ID: 31797627
[TBL] [Abstract][Full Text] [Related]
20. A Practical Guide to The Cancer Genome Atlas (TCGA).
Wang Z; Jensen MA; Zenklusen JC
Methods Mol Biol; 2016; 1418():111-41. PubMed ID: 27008012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
